how does semaglutide work for insulin resistance vs. Tirzepatide: Which GLP-1 Wins? GLP-1 Agonists - What is

Recent studies have shown that patients on high-dose semaglutide can lose an average of 15% to 20% of their body weight, a level previously achievable only with bariatric surgery

While mild muscle discomfort during weight loss may not require immediate medical attention, certain features warrant prompt clinical evaluation to exclude serious underlying conditions

Patients in states with limited pharmacy partner coverage

It is TGA-approved and available in Australia through private prescription

It's a ready-to-use formulation that doesn't require reconstitution, improving convenience compared to the original lyophilized Egrifta and Egrifta SV versions

The STEP 4 trial demonstrated that participants who discontinued semaglutide after 20 weeks regained approximately two-thirds of lost weight over the next 48 weeks